Company: INTS
Filing Date: 2025-04-25
Form Type: 424B4
Source: 0001628280-25-020056
Chunk: 2

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-04-25
Form: 424B4
Chunk 2
---
 this offering. Further, any proceeds from the sale of securities offered by us will be available for our immediate use, despite uncertainty about whether we would be able to use such funds to effectively implement our business plan. See the section entitled “Risk Factors” for more information.

Our Common Stock is listed on The Nasdaq Capital Market (Nasdaq”) under the symbol “INTS”. On April 24, 2025, the last reported sale price of our Common Stock on Nasdaq was $0.90 per share. The actual public offering price per share of Common Stock and accompanying Common Warrants was negotiated between us, the Placement Agents and the investors in this offering at the time of pricing. There is no established public trading market for the Common Warrants, and we do not expect such a market to develop. Without an active trading market, the liquidity of the Common Warrants will be limited. In addition, we do not intend to list the Common Warrants on Nasdaq, any other national securities exchange or any other trading system.

Investing in our securities involves risks. You should review carefully the risks and uncertainties described under the heading “ Risk Factors ” contained in this prospectus and under similar headings in the other documents that are incorporated by reference into this prospectus, as described beginning on page 8 of this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities to be issued under this prospectus or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

|                                    |     | Per Share of Common Stock and Accompanying Common Warrants |        |     | Total |              |
|:-----------------------------------|:----|:-----------------------------------------------------------|-------:|:----|:------|-------------:|
| Public offering price(1)           |     | $                                                          | 0.7500 |     | $     | 2,349,999.75 |
| Placement Agents’ fees(2)          |     | $                                                          | 0.0525 |     | $     |   164,499.98 |
| Proceeds to us, before expenses(3) |     | $                                                          | 0.6975 |     | $     | 2,185,499.77 |

__________________

(1) The combined public offering price is $0.75 per share of Common Stock and accompanying Common Warrants.

(2) Represents a cash fee equal to seven percent (7.0